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httpcense.Abstract Background: OSA is associated with an increased prevalence of coronary artery disease,
heart failure and rhythm disturbance. Also, P-wave dispersion (Pd) reﬂects inhomogeneous atrial
depolarization secondary to insults such as chronically elevated atrial pressure, ischemia, or meta-
bolic stress that promote atrial structure remodeling and provide a substrate for atrial ﬁbrillation.
We aimed to investigate Pd in patients with OSA and to determine if there is any relationship with
severity of the disease.
Patients and methods: This study was conducted in Chest & Cardiology Departments, Assuit
University Hospital, Egypt on 40 OSA patients (29 males and 11 females), and 20 healthy controls.
We excluded patients with COPD and any diagnosed cardiac disease. For every patient, we did a
polysomnography and ECG.
Results: Pd was signiﬁcantly more in OSA (98.50 ± 4.77 m/s) than controls (72.00 ± 3.37 m/s)
(p value <0.05). Pd in severe, moderate and mild OSA were 111.43 ± 5.62 m/s, 95.00 ± 7.83 m/s
and 65.71 ± 8.41 m/s, respectively with a signiﬁcant positive correlation with severity of OSA. Mul-
tiple linear regression shows that systolic blood pressure and BMI are independently associated with
Pd (b= 0.56, p= 0.00) (b= 0.27, p= 0.05).
Conclusion: Pd is increased and correlated with severity of OSA. Systolic blood pressure and
BMI are independent risk factors for Pd. Follow up of patients to detect clinical implications is rec-
ommended.
ª 2013 The Egyptian Society of Chest Diseases and Tuberculosis. Production and hosting by Elsevier
B.V.Open access under CC BY-NC-ND license.971614.
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Obstructive sleep apnea (OSA) is an important diagnosis for
physicians to be considered because of its strong association
with some of the most debilitating medical conditions,
including hypertension, cardiovascular disease, coronary ar-is. Production and hosting by Elsevier B.V.
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Figure 1 Measurement by digital calipers of leads II and aVL
(side panels) demonstrated maximum and minimum P wave
durations, respectively: 128 and 85 ms, with resulting P wave
dispersion 23 ms.
Table 1 Clinical characteristics of the study population.
Character Number (%)
Male 29 (72.5%)
Female 11 (27.5%)
DM 13 (32.5%)
HTN 8 (20%)
Obesity 29 (72.5%)
Smoking 13 (32.5%)
Hypothyroidism 2 (0.5%)
Postmenopausal 5 (12.5%)
142 M. Metwally et al.tery disease, insulin-resistant diabetes, depression, and sleepi-
ness-related accidents [1].
It is characterized by repetitive upper airway collapse
resulting in drops of oxygen saturation and sleep fragmenta-
tion with cortical arousals and activation of the autonomic
nervous system. For a long time, OSA was recognized as a po-
tential cardiovascular risk factor [2].
The relationship between OSA and cardiovascular disease
has been attributed to many mechanisms such as increased
sympathetic activity, oxidative stress, inﬂammation, metabolic
disturbance and endothelial dysfunction [3].
P wave prolongation is an intermediate step in the accumu-
lation of insults ultimately leading of AF [4].
The prolongation of intra-atrial and inter-atrial conduction
time and the inhomogeneous propagation of sinus impulses are
well known electro physiological characteristics of the atrium
prone to ﬁbrillate and have been evaluated using a simple elec-
trocardiographic (ECG) marker which is P-wave dispersion
(Pd) [5,6].
P wave dispersion is deﬁned as the difference between the
maximum and minimum duration of P waves [7].
We aimed to investigate Pd in patients with OSA and to
determine if there is any relationship with severity of the
disease.
Patients and method
Our cross-sectional study was conducted at Cardiology and
Chest Diseases Departments, Assuit University Hospital,
Egypt.
Inclusion criteria
Patients were diagnosed according to International Classiﬁca-
tion of Sleep Disorders published by the American Academy
of Sleep, which stated that, diagnosis of obstructive sleep apnea
could be made if the respiratory disturbance index (RDI) is
P15, independent of occurrence of symptoms, or whenever
an RDI > 5 is associated with any of the following: [8]
(1) Sleep attacks, excessive daytime sleepiness (EDS), unre-
freshing sleep, fatigue or insomnia
(2) Awakenings with a choking sensation; or
(3) Witnessed heavy snoring and/or breathing pauses
referred by the partner (The patient may be unaware
of this symptom – usually the bed partner is extremely
aware of this).
Exclusion criteria
 Patients with COPD
 Pacemaker implantation, permanent or paroxysmal
atrial ﬁbrillation
 Pericarditis, valvular heart disease, pulmonary emboli
 Cardiomyopathies, pulmonary hypertension, abnormal
serum electrolyte values, receiving any ant arrhythmic
drugs, and
 Coronary artery disease
All patients were subjected to the following:1. Full clinical history taking and clinical examination
2. ECG
All standard 12-lead ECGs were obtained simultaneously
using a recorder set at 50 mm/s paper speed and 2 mV/cm stan-
dardization in a comfortable supine position. For standardiza-
tion, ECG was taken between 10 and 11 a.m. During ECG
recordings all patients breathed freely and did not speak.
ECGs were numbered and presented to the analyzing investi-
gators without name and date information. P-wave duration
was measured manually in all simultaneously recorded 12 leads
of the surface ECG. The onset of the P wave was deﬁned as the
point of ﬁrst visible upward departure from baseline for posi-
tive waveform, and as the point of ﬁrst downward departure
from baseline for negative waveforms. The return to the base-
line was considered to be the end of the P wave. The difference
between the Pmax and the Pmin was calculated and deﬁned as P
wave dispersion (Fig. 1) [9].
Table 2 P-wave measurements and level of OSA.
P-wave Level of OSA P-value
Mild (Mean ± SD) Moderate (Mean ± SD) Severe (Mean ± SD)
P-wave minimum 88.57 ± 12.99 78.33 ± 10.86 68.57 ± 6.70 0.395
P-wave maximum 154.29 ± 11.31 173.33 ± 10.25 180.00 ± 7.93 0.293
P-wave dispersion 65.71 ± 8.41 95.00 ± 7.83 111.43 ± 5.62 0.003
Table 3 Correlation between P wave dispersion and disease
variables.
Disease variables Correlation (r) P value
AHI 0.43 0.006
BMI 0.64 0.000
Systolic blood pressure 0.64 0.000
Diastolic blood pressure 0.20 0.116
Age 0.18 0.17
AHI, apnea hyponea index; BMI, body mass index.
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Polysomnography (PSG)
It was done overnight at Assiut chest department sleep labora-
tory, with monitoring of oxygen saturation, heart rate, sleep
stage by electroencephalography, nasal airﬂow, oral airﬂow,
jaw muscle tone by electromyography, sleep position, and
chest and abdominal movement.
The Apnea–Hypopnea Index (AHI) was calculated as the
number of apneas and hypopneas per hour of sleep.
 Patients with AHI (5–15) were considered to have mild
OSA.
 AHI (15–30) were considered to have moderate OSA.
 AHI (>30) were considered to have severe OSA.
Statistical analysis
Data were analyzed by statistical package for the social sci-
ences (SPSS, version 16.0).
Continuous variables were expressed as Mean + SD, while
categorical variables were displayed in numbers and
percentages.Table 4 Multiple linear regression analysis (P-wave dispersion).
Unstandardized coeﬃcients
B Std. Error
(Constant) 56.488 38.542
Age 0.365 0.310
Systolic BP 1.343 0.285
Diastolic BP 0.718 0.360
AHI 0.180 0.133
BMI 1.690 0.814Continuous variables were compared among the groups of
patients with one-way ANOVA test for normally distributed
data, while chi-square tests were performed for nominal
variables.
Correlations between all variables were calculated with the
Pearson correlation coefﬁcient. Multiple linear regression anal-
ysis was utilized to identify the factors related to P wave dis-
persion. P< 0.05 was considered signiﬁcant.
Results
We recruited 40 obstructive sleep apnea patients with a mean
age ± SD of 48.68 ± 10.61 years and 20 healthy controls from
March 2012 to April 2013. Baseline clinical characteristics of
the study population are shown in Table 1.
Among our patients, 21 (52.5%) patients had severe
obstructive sleep apnea, 12 (30%) patients had moderate
OSA and 7 (17. 5%) patients had mild OSA.
Apnea–Hypopnea Index (AHI) value range was 9–111/h
with mean 41.06 ± 4.42.
P wave maximum was higher in OSA patients than controls
173.50 ± 5.61 m/s versus 145.00 ± 5.60 m/s, (p value <0.05).
P wave minimum in OSA patients was 75.00 ± 5.30 m/s
and in controls was 73.00 ± 5.85 m/s (p value >0.05).
P wave dispersion in OSA patients was higher than control
persons 98.50 ± 4.77 m/s versus 72.00 ± 3.37 m/s, (p value
<0.05).
Moreover, P wave dispersion was higher in severe thanmod-
erate and inmoderate thanmild grade ofOSA111.43 ± 5.62 m/s
versus 95.00 ± 7.83 m/s and 65.71 ± 8.41 m/s respectively (p
value <0.05) (Table 2).
There was a signiﬁcant positive correlation between P wave
dispersion and the AHI, Systolic blood pressure, Body mass
index with r values 0.43, 0.64 and 0.64, respectively (Table 3).
Among risk factors, multiple linear regression analysis
showed that; systolic blood pressure and BMI are indepen-
dently associated with Pd (b= 0.56, p= 0.00) (b= 0.47,
p= 0.05) (Table 4).Standardized coeﬃcients T P-value
Beta
1.466 0.152
0.128 1.179 0.247
0.568 4.719 0.000
0.221 1.993 0.054
0.167 1.362 0.182
0.272 2.077 0.045
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In our study, P wave maximum was higher in OSA patients
than controls. Moreover, P wave dispersion was higher in se-
vere and moderate than mild grade of obstructive sleep apnea.
There was a signiﬁcant positive correlation between P wave
dispersion and AHI.
Factors related to OSA, such as repetitive hypoxemia, auto-
nomic nervous system imbalance, systemic inﬂammation, ﬂuc-
tuations in intrathoracic hemodynamic, and diastolic
dysfunction may lead to prolongation of inrta-atrial and in-
ter-atrial conduction time and provoke inhomogeneous prop-
agation of sinus impulses reﬂected as increased Pmax and P
wave dispersion [5]. The Sleep Heart Health Study has re-
ported a fourfold increase in the prevalence of atrial ﬁbrillation
in subjects with an AHI > 30 [10].
We found a signiﬁcant positive correlation between P wave
dispersion and body mass index. This is because obesity is con-
sidered a major risk factor for the development and progres-
sion of OSA [11].
Moreover, obesity may worsen OSA because of fat deposi-
tion at speciﬁc sites. Fat deposition in the tissues surrounding
the upper airway appears to result in a smaller lumen and in-
creased collapsibility of the upper airway predisposing to ap-
nea [12,13].
There was a signiﬁcant positive correlation between P wave
dispersion and Systolic and diastolic blood pressure this may
be explained by Left ventricular diastolic dysfunction in hyper-
tensive patients which may result in an increase in left ventric-
ular end-diastolic (LVED) pressure and in left atrial
dimensions. The increase in left atrial dimensions as a result
of rising intra-atrial pressure changes the geometry of atrial ﬁ-
brils; this, in combination with inhomogeneous ﬁbrosis of the
left atrial wall, interrupts the conduction of sinus impulses,
which induce P wave dispersion [14–17].
To conclude, Pd is increased and correlated with severity of
OSA. Systolic blood pressure and BMI are independent risk
factors for Pd. Follow up of patients to detect clinical implica-
tions is recommended.
Study limitations
The small number of patients and the manual measurement of
P-wave instead of computer-assisted measurement are the
main drawbacks of our study. Follow up of the patients in or-
der to evaluate the signiﬁcance of Pd may be a topic for future
studies.
Conﬂict of interest
None declared.
References
[1] Jo-Dee L. Lattimore, David S. Celermajer, Obstructive sleep
apnea and cardiovascular disease, J. Am. Coll. Cardiol. vol. 41
(9) (2003).[2] S. Andreas, G. Hajak, B. Breska, E. Ru¨ther, H. Kreuzer,
Changes in heart rate during obstructive sleep apnea, Eur.
Respir. J. 5 (1992) 853–857.
[3] A.S. Shamsuzzaman, B.J. Gersh, V.K. Somers, Obstructive
sleep apnea: implications for cardiac and vascular disease, J.
Am. Med. Assoc. 290 (14) (2003) 1906–1914.
[4] S. Kose, K. Aytemir, E. Sade, et al, Detection of patients with
hypertrophic cardiomyopathy at risk for paroxysmal atrial
ﬁbrillation during sinus rhythm by P-wave dispersion, Clin.
Cardiol. 26 (9) (2003) 431–434.
[5] M. Niroumand, R. Kuperstein, Z. Sason, P.J. Hanly, Impact of
obstructive sleep apnea on left ventricular mass and diastolic
function, Am. J. Respir. Crit. Care Med. 163 (2001) 1632–1636.
[6] G. Boriani, I. Diemberger, M. Bifﬁ, et al, P-wave dispersion and
short-term vs. late atrial ﬁbrillation recurrences after
cardioversion, Int. J. Cardiol. 101 (2005) 355–361.
[7] P. Dilaveris, E.J. Gialafos, S. Sideris, et al, Simple
electrocardiographic markers for the prediction of paroxysmal
idiopathic atrial ﬁbrillation, Am. Heart J. 135 (1998) 733.
[8] American Academy of Sleep Medicine Task Force, Sleep-
related breathing disorders in adults: recommendations for
syndrome deﬁnition and measurement techniques in clinical
research, Sleep 22 (2001) 667–689.
[9] J.W. Magnani, V.M. Johnson, L.M. Sullivan, et al, P wave
duration and risk of longitudinal atrial ﬁbrillation in persons
P60 years old (from the Framingham Heart Study), Am. J.
Cardiol. 107 (6) (2011) 917–921.
[10] R. Mehra, E.J. Benjamin, E. Shahar, D.J. Gottlieb, R. Nawabit,
H.L. Kirchner, J. Sahadevan, S. Redline, Association of
nocturnal arrhythmias with sleep-disordered breathing: the
sleep heart health study, Am. J. Respir. Crit. Care Med. 173
(2006) 910–916.
[11] L.G. Fritscher, C.C. Mottin, S. Canani, J.M. Chatkin, Obesity
and obstructive sleep apnea–hypopnea syndrome: the impact of
bariatric surgery, Obes. Surg. 171 (2007) 95–99.
[12] O. Resta, M.P. Foschino-Barbaro, G. Legari, et al, Sleep-
related breathing disorders, loud snoring and excessive daytime
sleepiness in obese subjects, Int. J. Obes. Relat. Metab. Disord.
255 (2001) 669–675.
[13] R.J. Schwab, M. Pasirstein, R. Pierson, et al, Identiﬁcation of
upper airway anatomic risk factors for obstructive sleep apnea
with volumetric magnetic resonance imaging, Am. J. Respir.
Crit. Care Med. 1685 (2003) 522–530.
[14] K.E. Shelton, H. Woodson, S. Gay, P.M. Suratt, Pharyngeal fat
in obstructive sleep apnea, Am. Rev. Respir. Dis. 1482 (1993)
462–466.
[15] R.J. Myeburg, K.M. Kessler, A. Castellanos, Recognition,
clinical assessment and management of arrhythmias and
conduction disturbances, in: R.W. Alexander, R.C. Schlant, V.
Fuster (Eds.), Hurst’s the Heart, Arteries and Veins, ninth ed.,
McGraw-Hill, New York, 1998, pp. 873–941.
[16] S. Ciaroni, L. Cuenoud, A. Bloch, Clinical study to investigate
the predictive parameters for the onset of atrial ﬁbrillation in
patients with essential hypertension, Am. Heart J. 139 (2000)
814–819.
[17] A.S. Gami, G. Pressman, S.M. Caples, et al, Association of
atrial ﬁbrillation and obstructive sleep apnea, Circulation 110
(2004) 364–367.
